We will enter into a joint research agreement with Kyoto University and engage in R&D projects.
・Approved category: Category III (Full-scale business development)
・Approved theme: Promoting the development of next-generation immunotherapeutic drugs for cancer with the goal of creating a society with zero cancer deaths
*Click here for a list of approved parties.